The stock of Conformis Inc. (NASDAQ:CFMS) increased by remained unchanged at $1.27, up 0.79 percent. The last five days have seen an average of 2,024,040 shares of common stock traded. 17 times new highs were reached in the current year, with a gain of $0.6100. The average number of shares traded over the last 20 days was 1,815,305, while the average volume over the last 50 days totaled 2,541,912.
CFMS stock dropped -14.77% since last month. On 10/19/21, the company’s shares reached a one-month low of $1.1500. The stock touched a high of $1.96 on 09/13/21, after rallying from a low of $0.60 in 52 weeks. The price of CFMS stock has risen by 92.42% or $0.6100 this year, reaching a new high 17 times. Still, the stock price is down -35.04% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
There have been 76 days since Conformis Inc. (CFMS) last reported insider trading activity on Aug 10. On Aug 10, President & CEO Augusti Mark A sold 5,000 shares at $1.40 each. This transaction resulted in the insider making $7,000. On Aug 09, Augusti Mark A sold 7,493 shares at a price of US$1.42. After the transaction, the insider now owns 2,576,324 shares. CLO & SECRETARY ALLDREDGE J BRENT had earlier sold 3,749 shares on Jul 29 for $1.47 a share. The transaction was completed for $5,511.
Beta for the stock is 1.33. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 2.27, the price-to-book (PB) ratio of 1.79.
For the three months ended June 29, Conformis Inc.’s quick ratio was 8.80, while its current ratio was 9.70, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.16, and the total debt to equity ratio is 0.16. As far as profitability goes, gross margin for the trailing twelve months is 67.20% percent. Conformis Inc.’s EBITDA margin for the year ended June 29 was -28.46%, whereas its operating margin stood at 6.70% for the same period. Based on annual data, it had gross profit of $33.72 million and revenue of $68.76 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. CFMS’s return on assets (ROA) during the last 12 months has been 11.80%. There was a -69.10% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 22.60%. ROE has averaged 3.96 in the past year for the broader industry.
According to Conformis Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $56.35 million, while revenues rose by 65.45% to $13.84 million. It was predicted that Conformis Inc.’s quarterly earnings would be $0.21, but it ended up being $0.04, beating the consensus by 425.00%. EBITDA was $31.93 million for the quarter. At the end of Conformis Inc.’s most recent quarter ended June 29, its liabilities totaled 43.03 million, while its total debt was $30.68 million. Equity owned by shareholders amounts to $185.96 million.
Here’s a quick look at Conformis Inc.’s (CFMS) price momentum from a technical perspective. As of 22 October, the RSI 9-day stood at 46.02%, suggesting the stock is Neutral, with a 66.20% historical volatility rate.
The stochastic %K and %D were 58.51% and 54.71% respectively, while the average true range (ATR) was 0.0901. Based on the 14-day stochastic reading of 63.83%, the RSI (14) reading is 44.14%. On the 9-day MACD Oscillator, the stock is at 0.0144.
Conformis Inc. (NASDAQ: CFMS) was downgraded by BTIG Research to a a Neutral rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Conformis Inc. (CFMS) an Overweight rating. CFMS is a stock that is recommended for selling by 1 brokerage firm, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 3 others recommend it as a buy.
What is CFMS’s price target for the next 12 months?
The current consensus forecast for the stock is between $2.00 and $2.50, with a median target price of $2.00. In analyzing these forecasts, the average price target given by analysts for Conformis Inc. (CFMS) is $2.17.